Polyphor AG | WebDisclosure

Basculer en Français

8607	Companies
141266	Keywords
77178	Articles
75486	Press releases

Home
Companies
Polyphor AG

PRESS RELEASE

published on 04/30/2024 at 20:30, 11 months 9 days ago

Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024.
Spexis AG receives approval to extend deadline for publishing 2023 annual report and audited financials until May 31, 2024, due to ongoing legal discussions and negotiations with creditors

Extension 2023 Annual Report Spexis AG Deadline Audited Financials
BRIEF

published on 04/17/2024 at 07:20, 11 months 22 days ago

Spexis AG annonce des développements importants, notamment un moratoire prolongé et des modifications stratégiques en matière de licences

Spexis SA Prolongation Du Moratoire OMPTA Vente De Programmes Précliniques Licence Lonodelestat
BRIEF

published on 04/17/2024 at 07:20, 11 months 22 days ago

Spexis AG Announces Significant Developments Including Extended Moratorium and Strategic Licensing Changes

Spexis AG Moratorium Extension OMPTAs Preclinical Program Sale Lonodelestat Licensing
PRESS RELEASE

published on 04/17/2024 at 07:15, 11 months 22 days ago

Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and reversion of the lonodelestat license from Santhera
Spexis AG extends moratorium and receives payment for antibiotics program sale while reverting lonodelestat license from Santhera

Spexis AG Moratorium Extension Antibiotics Program Sale Lonodelestat License Santhera
PRESS RELEASE

published on 02/08/2024 at 07:15, 1 year 2 months ago

Spexis announces closing of sale of preclinical antibiotics program to Basilea
Spexis AG announces the closing of the sale of a preclinical antibiotics program to Basilea, which will pay up to CHF 2 million for the program. The program targets Gram-negative bacteria, including multidrug-resistant strains. The sale is part of Spexis' strategy to divest non-core programs and assets to focus on rare diseases and oncology

Spexis AG Basilea Preclinical Antibiotics Program Gram-negative Bacteria Multidrug-resistant Strains
PRESS RELEASE

published on 11/08/2023 at 07:15, 1 year 5 months ago

Spexis to file an application for a debt-restructuring moratorium
PRESS RELEASE

published on 11/01/2023 at 07:20, 1 year 5 months ago

Spexis Announces Changes to the Executive Committee
PRESS RELEASE

published on 10/06/2023 at 07:30, 1 year 6 months ago

Spexis to host business update conference call on October 9, 2023
PRESS RELEASE

published on 09/29/2023 at 07:25, 1 year 6 months ago

Spexis provides business update and announces financial results for the first half of 2023
PRESS RELEASE

published on 09/28/2023 at 07:30, 1 year 6 months ago

Spexis announces the appointment of Gonçalo Bernardes, Ph.D., as acting Head of Chemical Biology

Accesswire

Published on 04/10/2025 at 06:08, 9 minutes ago

Tocvan Commences Drilling at Gran Pilar Gold - Silver Project Continues Expansion Zone Drilling Along Northern Corridors
Published on 04/10/2025 at 02:30, 3 hours 47 minutes ago

Star Copper Completes Non-Brokered Private Placement for Proceeds of $2,500,000
Published on 04/10/2025 at 01:40, 4 hours 37 minutes ago

RRS Gather Round Conference Presentation
Published on 04/09/2025 at 23:30, 6 hours 47 minutes ago

AirIQ Announces Major Customer Win Accelerating Growth in Recurring Revenue
Published on 04/09/2025 at 22:17, 8 hours ago

Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details

View all ACCESSWIRE

EQS Group

Published on 04/10/2025 at 04:55, 1 hour 22 minutes ago

CO2Coin one of the most successful crypto investments of the coming decades.
Published on 04/09/2025 at 20:20, 9 hours 57 minutes ago

Zimbabwe Government Delivers on Commitment: Compensation of Former Farm Owners under the Global Compensation Deed Commences
Published on 04/09/2025 at 20:18, 9 hours 59 minutes ago

EQS-Adhoc: VOLKSWAGEN AKTIENGESELLSCHAFT: Volkswagen AG publishes preliminary key figures for the financial statements as of March 31, 2025
Published on 04/09/2025 at 19:08, 11 hours 8 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/09/2025 at 18:45, 11 hours 32 minutes ago

EUROPLASMA: Précisions dans le cadre du projet de reprise de la Fonderie de Bretagne

Les Echos

Published on 04/09/2025 at 18:59, 11 hours 17 minutes ago

Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:59, 11 hours 17 minutes ago

Descriptif du programme de rachat d'actions 2025-2026
Published on 04/09/2025 at 18:57, 11 hours 19 minutes ago

Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 18:57, 11 hours 19 minutes ago

Compte-rendu de l'Assemblée Générale Mixte du 9 avril 2025
Published on 04/09/2025 at 17:45, 12 hours 32 minutes ago

COGELEC : Résultats annuels 2024 et Chiffre d’affaires du 1 er trimestre 2025.

View all LES ECHOS COMFI WIRE